BeOne Medicines Ltd. - Sponsored ADR ONC

360.85 0.88 0.24% as of 25 Sep
Market cap
$37.3B
P/E
61.2×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
368.17 837.52 1,795.99 983.03 4,650.98 6,617.97 4,535.01 3,171.80 2,627.41 4,547.53
Receivables
— 29.43 41.06 70.88 60.40 483.11 173.17 358.03 676.28 865.08
Inventory
— 10.93 16.24 28.55 89.29 242.63 282.35 416.12 494.99 608.23
Total current assets
374.40 913.50 1,943.84 1,172.70 4,960.69 7,613.88 5,207.08 4,203.41 3,991.59 6,233.59
Property, Plant, Equpment (Net)
25.98 62.57 157.06 242.40 357.69 587.61 845.95 1,324.15 1,578.42 1,641.68
Goodwill and Intangible Assets (Total)
— 19.82 52.23 5.85 5.00 46.68 40.62 57.14 51.10 62.70
Long Term Assets (Tax, Deferred)
0.77 7.68 29.54 37.89 65.96 110.42 — — — —
Long-term assets (Other)
4.67 42.92 67.01 70.93 120.84 169.93 175.69 125.36 160.49 102.42
Total non-current assets
31.41 132.98 305.84 439.59 640.07 921.65 1,172.21 1,601.86 1,929.32 1,954.98
Total Assets
405.81 1,046.48 2,249.68 1,612.29 5,600.76 8,535.53 6,379.29 5,805.28 5,920.91 8,188.57
Notes Payable
— — — — 335.02 427.57 328.97 688.37 851.53 57.29
Accounts Payable
11.96 69.78 113.28 122.49 231.96 262.40 294.78 315.11 405.00 479.04
Accrued Expenses
22.30 49.60 100.41 163.56 346.14 558.06 467.35 693.73 803.71 1,109.12
Current Part of Debt
— 9.22 8.73 10.78 349.03 449.23 328.97 688.37 — —
Current Part of Taxes to Pay
0.80 9.16 5.89 13.45 20.38 21.40 25.19 22.95 25.93 41.63
Current Revenue (Deferred)
— 12.23 18.14 — — 187.41 213.86 — — —
Other current liabilities
22.29 61.84 118.52 163.54 127.81 120.80 114.34 68.00 111.15 121.06
Total current liabilities
35.06 149.99 246.45 310.31 1,075.20 1,599.56 1,468.53 1,810.11 2,214.90 1,828.83
Long Term Debt (Total)
17.28 155.49 189.67 240.70 183.64 202.11 209.15 197.62 166.48 961.91
Non-current Revenue (Deferred)
— 24.81 9.83 — — 220.29 42.03 0.30 — —
Long Term Tax Liability (Deferred)
(0.77) (7.68) 11.14 10.53 10.79 14.17 16.00 16.49 42.01 53.21
Non-current Liabilities (Other)
0.56 31.96 48.77 46.56 432.47 323.80 225.72 221.47 121.02 930.49
Total non-current liabilities
17.85 212.26 249.59 323.62 656.31 803.41 527.41 457.84 373.79 1,998.55
Total liabilities
52.91 362.25 496.04 633.93 1,731.51 2,402.96 1,995.94 2,267.95 2,588.69 3,827.38
Additional Paid In Capital
591.21 1,000.75 2,744.81 2,925.97 7,414.93 11,191.01 11,540.98 11,598.69 12,087.91 12,759.14
Common Stock (Net)
0.05 0.06 0.08 0.08 0.12 0.13 0.14 0.14 0.14 0.14
Retained Earnings
(237.41) (330.52) (1,007.21) (1,955.84) (3,552.75) (5,076.53) (7,080.34) (7,962.05) (8,606.84) (8,319.90)
Common Equity (Total)
352.91 684.23 1,753.65 978.36 3,869.24 6,132.56 4,383.35 3,537.33 3,332.22 4,361.19
Shareholders Equity (Total)
352.91 684.23 1,753.65 978.36 3,869.24 6,132.56 4,383.36 3,537.33 3,332.22 4,361.19
Shareholders Equity and Liabilities (Total)
405.81 1,046.48 2,249.68 1,612.29 5,600.76 8,535.53 6,379.29 5,805.28 5,920.91 8,188.57
Shares (Common)
39.68 45.54 59.71 61.64 91.60 102.68 104.32 104.88 106.72 110.85
Shareholders Equity (Tangible)
352.91 664.41 1,701.42 972.51 3,864.24 6,085.88 4,342.74 3,480.19 3,281.13 4,298.49
Net Debt
(350.89) (672.80) (1,597.59) (731.55) (4,118.31) (5,966.62) (3,996.89) (2,285.82) (2,460.93) (3,585.62)
Total Debt
17.28 164.72 198.40 251.48 532.67 651.34 538.12 885.98 166.48 961.91

Fold the line items

In millions of $ except per-share values · columns are period end dates